The pharmacokinetic and bactericidal characteristics of oral cefixime
- PMID: 4053491
- DOI: 10.1038/clpt.1985.229
The pharmacokinetic and bactericidal characteristics of oral cefixime
Abstract
The pharmacokinetics of cefixime (FK 027), a broad-spectrum cephalosporin, were assessed in 12 normal subjects after single oral doses of 50, 100, 200, and 400 mg. Mean peak serum concentrations were 1.02, 1.46, 2.63, and 3.85 micrograms/ml after the four respective doses. Respective mean serum levels at 12 hours were 0.16, 0.33, 0.72, and 1.13 micrograms/ml. Volumes of distribution averaged 0.1 L/kg body weight, and the elimination t1/2 was 3 hours for all doses. The AUC was 7.01, 11.4, 22.5, and 36.4 micrograms X hr/ml for the four doses, respectively. Serum clearance averaged 0.4 mg/min/kg and mean 24-hour urinary recovery was 21%, 19%, 20%, and 16% for the four respective doses. Serum bactericidal titers at 4 hours exceeded 1:16 for Streptococcus pneumoniae, S. pyogenes, Hemophilus influenzae, and Branhamella catarrhalis. Urine bactericidal titers exceeded 1:8 for Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae resistant to the available oral cephalosporins.
Similar articles
-
Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential.Drugs. 1989 Oct;38(4):524-50. doi: 10.2165/00003495-198938040-00004. Drugs. 1989. PMID: 2684593 Review.
-
In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime.Pediatr Infect Dis J. 1987 Oct;6(10):958-62. doi: 10.1097/00006454-198710000-00034. Pediatr Infect Dis J. 1987. PMID: 3696836
-
[Bacteriological, pharmacokinetic and clinical studies of 5% and 10% granules of cefdinir in the pediatric field].Jpn J Antibiot. 1992 Jan;45(1):48-73. Jpn J Antibiot. 1992. PMID: 1495196 Clinical Trial. Japanese.
-
[Fundamental and clinical studies on cefixime in pediatrics].Jpn J Antibiot. 1986 Apr;39(4):1087-105. Jpn J Antibiot. 1986. PMID: 3761539 Japanese.
-
[Cefixime. Microbiologic, kinetic and clinical profile].Minerva Med. 1991 Oct;82(10):633-56. Minerva Med. 1991. PMID: 1745375 Review. Italian.
Cited by
-
Pharmacokinetics of cefixime (CL 284,635; FK 027) in healthy subjects and patients with renal insufficiency.Antimicrob Agents Chemother. 1986 Sep;30(3):485-90. doi: 10.1128/AAC.30.3.485. Antimicrob Agents Chemother. 1986. PMID: 3777912 Free PMC article.
-
In vitro susceptibility of Haemophilus influenzae to cefixime.Antimicrob Agents Chemother. 1987 Nov;31(11):1841-2. doi: 10.1128/AAC.31.11.1841. Antimicrob Agents Chemother. 1987. PMID: 3501703 Free PMC article.
-
Treatment of acute uncomplicated urinary tract infection with ceftibuten.Infection. 1991 Mar-Apr;19(2):124-6. doi: 10.1007/BF01645584. Infection. 1991. PMID: 2050421
-
Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential.Drugs. 1989 Oct;38(4):524-50. doi: 10.2165/00003495-198938040-00004. Drugs. 1989. PMID: 2684593 Review.
-
Pharmacokinetics of newer drugs in patients with renal impairment (Part I).Clin Pharmacokinet. 1991 Apr;20(4):293-310. doi: 10.2165/00003088-199120040-00004. Clin Pharmacokinet. 1991. PMID: 2036748 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources